Results 261 to 270 of about 280,656 (362)

Coronary Artery Bypass Surgery in Patients on Dialysis: In-Hospital Outcomes from UK Registry Analysis. [PDF]

open access: yesInterdiscip Cardiovasc Thorac Surg
Mashat MA   +9 more
europepmc   +1 more source

Ablation of Ventricular Tachycardia Using the QDOT MICRO Ablation Catheter (VT‐MICRO Study)

open access: yesJournal of Arrhythmia, Volume 42, Issue 1, February 2026.
Catheter ablation is useful to treat patients with ventricular tachycardia. QDOT Micro catheter is a next generation catheter designed to provide more efficient lesion creation with an accurate myocardial substrate analysis. Microelectrode mapping allows detection of higher voltage electrograms compared to standard bipolar mapping and Pentaray mapping.
Antonio Di Monaco   +6 more
wiley   +1 more source

Long-Term Clinical Outcomes of Minimally Invasive Direct Coronary Artery Bypass Grafting. [PDF]

open access: yesJ Clin Med
Aboul-Hassan SS   +8 more
europepmc   +1 more source

Comparison between the NUTRIC score and modified NUTRIC score to predict hospital mortality in patients undergoing cardiac surgery: A retrospective study

open access: yesNutrition in Clinical Practice, Volume 41, Issue 1, Page 166-176, February 2026.
Abstract Background Nutrition status evaluation is essential for patients undergoing cardiac surgery. The Nutrition Risk in the Critically Ill (NUTRIC) and modified NUTRIC (mNUTRIC) scores are nutrition risk assessment tools specifically for patients in the intensive care unit (ICU).
Jing Xu   +8 more
wiley   +1 more source

Platelet-to-Hemoglobin Ratio in Predicting Major Adverse Cardiovascular Events After Coronary Artery Bypass Grafting. [PDF]

open access: yesVasc Health Risk Manag
Chen S   +10 more
europepmc   +1 more source

Exploring Pembrolizumab‐Induced IM3OS in a Patient With Bladder Cancer

open access: yesPharmacology Research &Perspectives, Volume 14, Issue 1, February 2026.
ABSTRACT Pembrolizumab, an immune checkpoint inhibitor (ICI), has transformed cancer treatment across various malignancies, including metastatic urothelial cancer. As the use of pembrolizumab becomes increasingly widespread, understanding its potential adverse effects is essential.
Ching‐Cheng Chan   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy